Product Description: VX-150 is an orally active, highly selective NaV1.8 inhibitor. VX-150 has the potential for various pain indications research[1].
Applications: Neuroscience-Neuromodulation
Formula: C21H17F4N2O7P
References: [1]Hemme J Hijma, et al. A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Pharmacodynamic Effects of VX-150, a Highly Selective NaV1.8 Inhibitor, in Healthy Male Adults. Pain Med. 2021 Aug 6;22(8):1814-1826.
CAS Number: 1793080-72-4
Molecular Weight: 516.34
Compound Purity: 98.36
Research Area: Neurological Disease
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: Sodium Channel